For the Inventor, By the Inventor

Enter assignee name

San Francisco, CA, United States of America

Ubiome, Inc.

USPTO Granted Patents = 59

Trademarks = 7

Forward Citations = 360

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Zachary Apte (59 out of 94 patents)

Jessica Richman (59 out of 94 patents)

Daniel Almonacid (56 out of 89 patents)

4. Siavosh Rezvan Behbahani (12 out of 26 patents)

5. Catalina Valdivia (6 out of 7 patents)

6. Rodrigo Ortiz (5 out of 10 patents)

7. Inti Pedroso (4 out of 6 patents)

8. Paz Tapia (4 out of 6 patents)

9. Victoria Dumas (3 out of 3 patents)

10. Eduardo Morales (3 out of 8 patents)

Core Competencies:

Microbiome Analysis

Diagnostics

Therapeutics

Neurological Health

Cardiovascular Disease

Autoimmune Conditions

Cutaneous Conditions

Functional Features

Diet-Related Conditions

Locomotor System Conditions

Allergy-Related Conditions

Microorganism-Related Conditions

59 patents: Sort by Forward Citations

1. 10415105 - Method and system for diagnostic testing (2019-09-17),

2. 10410749 - Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions (2019-09-10),

3. 10409955 - Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions (2019-09-10),

4. 10388407 - Method and system for characterizing a headache-related condition (2019-08-20),

5. 10383519 - Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features (2019-08-20),

6. 10381117 - Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions (2019-08-13),

7. 10381112 - Method and system for characterizing allergy-related conditions associated with microorganisms (2019-08-13),

8. 10380325 - Method and system for microbiome-derived diagnostics and therapeutics (2019-08-13),

9. 10366793 - Method and system for characterizing microorganism-related conditions (2019-07-30),

10. 10366789 - Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues (2019-07-30),

11. 10366782 - Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions (2019-07-30),

12. 10360348 - Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues (2019-07-23),

13. 10360347 - Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues (2019-07-23),

14. 10360346 - Method and system for microbiome-derived diagnostics (2019-07-23),

15. 10358682 - Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features (2019-07-23),

uBiome, Inc. is a biotechnology company that specializes in microbial genomics. They focus on developing advanced sequencing-based tests to provide information about the human microbiome. Their innovative technology allows individuals to explore and understand their unique microbial populations, which can offer insights into various aspects of health and wellness.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

59 Patents

#86 in San Francisco, CA

#1,390 in California

#5,874 in US

#11,836 in the World

San Francisco, CA, United States of America

Ubiome, Inc.

Forward Citations = 360

10 inventors:

Zachary Apte (59 out of 94 patents)

Jessica Richman (59 out of 94 patents)

Daniel Almonacid (56 out of 89 patents)

4. Siavosh Rezvan Behbahani (12 out of 26 patents)

5. Catalina Valdivia (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…